MacroGenics
MGNX
#8590
Rank
NZ$0.32 B
Marketcap
NZ$5.10
Share price
-7.86%
Change (1 day)
130.92%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): NZ-$0.20

According to MacroGenics's latest financial reports the company's current EPS (TTM) is NZ-$0.08700. In 2024 the company made an earnings per share (EPS) of NZ-$1.86 a decrease over its 2023 EPS that were of NZ-$0.26.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.20-89.38%
2024NZ-$1.86613.33%
2023NZ-$0.26-92.31%
2022NZ-$3.39-42.14%
2021NZ-$5.8636.44%
2020NZ-$4.30-21.84%
2019NZ-$5.50-24.58%
2018NZ-$7.29675.93%
2017NZ-$0.94-68.05%
2016NZ-$2.94168.25%
2015NZ-$1.10-55%
2014NZ-$2.443400%
2013NZ-$0.06960-108.68%
2012NZ$0.8024.49%
2011NZ$0.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.37-2,820.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$40.06-46,148.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.93-28,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.92-13,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.72-14,720.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.02-7,020.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ-$3.08 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA